NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $729,000 | +767.9% | 191,842 | +1132.8% | 0.00% | – |
| Q1 2022 | $84,000 | -98.1% | 15,561 | -93.9% | 0.00% | -100.0% |
| Q4 2020 | $4,346,000 | +49.9% | 255,628 | +46.2% | 0.04% | +50.0% |
| Q3 2020 | $2,900,000 | +342.1% | 174,834 | +516.9% | 0.02% | +200.0% |
| Q2 2020 | $656,000 | -75.9% | 28,339 | -81.0% | 0.01% | -83.0% |
| Q3 2019 | $2,723,000 | -17.1% | 149,472 | +62.0% | 0.05% | -48.4% |
| Q2 2019 | $3,284,000 | -69.1% | 92,287 | -71.5% | 0.09% | -81.2% |
| Q4 2018 | $10,638,000 | +4259.8% | 323,645 | +13971.5% | 0.48% | +7950.0% |
| Q1 2018 | $244,000 | -97.4% | 2,300 | -98.5% | 0.01% | -97.0% |
| Q4 2017 | $9,231,000 | – | 154,564 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |